Bacillus calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
1976 • 1,617 citations
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
2016 • 1,466 citations
Cancer statistics, 1995
1995 • 1,434 citations
Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors
1976 • 978 citations
Carcinoma in situ.
1992 • 292 citations
LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER
1992 • 285 citations
COMPLICATIONS OF BACILLUS CALMETTE-GUÉRIN IMMUNOTHERAPY
1992 • 231 citations
Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: A 10-Year Followup
1992 • 210 citations
A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?
1991 • 179 citations
A Randomized Controlled Study of Intravesical α−2b-Interferon in Carcinoma in Situ of the Bladder
1990 • 171 citations
Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study.
1988 • 154 citations
Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder
1995 • 123 citations
Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin Therapy
1994 • 114 citations
Original Articles
1995 • 92 citations
BCG in Perspective: Advances in the Treatment of Superficial Bladder Cancer
1995 • 69 citations
Improving the Efficacy of BCG Immunotherapy by Dose Reduction
1995 • 66 citations
Improving the Safety of BCG Immunotherapy by Dose Reduction
1995 • 49 citations
Antiproliferative effects of bacillus Calmette-Gu�rin and interferon ?2b on human bladder cancer cells in vitro
1995 • 44 citations
Five-year results of a phase ii study with low-dose bacille calmette-guérin therapy in high-risk superficial bladder cancer
1995 • 34 citations
Intravesical interferon alfa in the treatment of superficial bladder cancer
1988 • 15 citations
High-dose versus low-dose intravesical interferon-α2b in the treatment of carcinoma in situ
1992 • 12 citations
Prospective, randomized trial to evaluate high-versus low-dose interferon-α2b versus conventional chemotherapy in prevention of the recurrence of superficial transitional cell carcinoma of the urinary bladder
1992 • 7 citations
Intravesical interferon alfa in the treatment of superficial bladder cancer.
1988 • 5 citations
Is a Prediction of Negative Margins and Continence Possible before Radical Prostatectomy?
1995 • 3 citations